DJIA 16,027.05 -177.92 -1.10%
NASDAQ 4,283.75 -79.39 -1.82%
S&P 500 1,853.44 -26.61 -1.42%
market minute promo

Gilead Sciences (NASDAQ: GILD)

85.26 0.12 (0.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $85.26 0.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $84.19
Previous Close $85.14
Daily Range $83.86 - $86.65
52-Week Range $81.89 - $123.37
Market Cap $122.9B
P/E Ratio 6.75
Dividend (Yield) $1.72 (2.0%)
Ex-Dividend Date
Dividend Pay Date
03/14/16
03/30/16
Volume 19,106,613
Average Daily Volume 13,002,527
Current FY EPS $12.00

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Will Gilead Sciences, Inc. Continue to Dominate HIV Treatment?

The launch of next generation therapies could help Gilead Sciences retain its market share.

Bristol-Myers' Daklinza-Sovaldi Label Expanded by the FDA

Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Cat

Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts

The 3 Most Undervalued Dividend Growth Stocks We Follow

Vertex Pharmaceuticals Has Great Upside Potential

3 Health Care Stocks On The Rise

How To Invest In An Aging World With The 'Live Long & Prosper' ETF

Why Gilead Sciences (GILD) Stock May Advance Today

Should Younger Investors Follow The Strategy Of Retirees In Allocating Capital?

Barron's: Here Comes $20 Oil

See More GILD News...

GILD's Top Competitors

GILD $85.26 (0.14%)
Current stock: GILD
AMGN $143.00 (-1.41%)
Current stock: AMGN
CELG $99.18 (1.32%)
Current stock: CELG
$0.00 (0.00%)
Current stock: